Clinical Trials Logo

Clinical Trial Summary

The study hypothesis is that spinal cord stimulation (SCS) combined with virtual leg illumination (provided through a wearable headset (OculusRift, OculusVR, Irvine, CA) and a custom-designed virtual reality leg scenario) will lead to controlled analgesia induction, boosting analgesic effects obtained with standard SCS treatments and will further be associated with changes in the perception of the affected body part.


Clinical Trial Description

Epidural spinal cord stimulation (SCS) is an approved treatment for truncal and extremity neuropathic pain. The mechanisms underlying the efficacy of SCS are unknown. Recent advances in cognitive neuroprosthetics using virtual reality allow for modulation of body perception and bodily experience, which has also been shown to modulate pain perception. The present research proposal plans to merge expertise in cognitive neuroprosthetics with neuromodulation techniques in order to test the analgesic properties of the combination of epidural spinal cord stimulation with a new system of multisensory stimulation based on virtual and enhanced reality (i.e., neuro-visual stimulation). The investigators propose to study this hypothesis prospectively in 25 patients with implanted SCS systems for the treatment of chronic neuropathic pain. Primary outcomes will be pain reduction (based on subjective, functional and physiological measures) and changes in body perception (based on subjective and objective measures). The present study will generate a proof-of-concept for the application of neuro-visual stimulation for the treatment of chronic pain and will form the basis for future NIH funding application. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02970006
Study type Interventional
Source Ohio State University
Contact
Status Completed
Phase N/A
Start date October 2016
Completion date November 2019

See also
  Status Clinical Trial Phase
Recruiting NCT04699734 - Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy N/A
Completed NCT04054804 - Digital Foot Check by Using the D-Foot, a New Software
Completed NCT05161364 - Kinetic Analysis Due to Foot Dysfunction
Not yet recruiting NCT03899298 - Safety and Clinical Outcomes With Amniotic and Umbilical Cord Tissue Therapy for Numerous Medical Conditions Phase 1
Recruiting NCT05291286 - BXQ-350 Pharmacokinetic/Pharmacodynamic Study in Cancer Patients Early Phase 1
Recruiting NCT04403802 - Voxx Human Performance Technology Socks for Chemotherapy-Induced Peripheral Neuropathy N/A
Enrolling by invitation NCT05590117 - Protective Effect of Pentoxifylline Against Chemotherapy Induced Toxicities in Patients With Colorectal Cancer Early Phase 1
Recruiting NCT05624138 - The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy Phase 3
Recruiting NCT06121232 - Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study N/A
Recruiting NCT05065554 - ACALA-R In Predominantly Demyelinating IgM Mediated Neuropathy Phase 2
Recruiting NCT05980767 - Short Duration Electrical Stimulation to Improve Outcomes After Cubital Tunnel Release (SELECT) Trial N/A
Completed NCT03135535 - Micro-mobile Foot Compression and Diabetic Foot Phase 2
Recruiting NCT03037684 - Depolarising Electrical Skin Stimulation in Neuropathic and Postoperative Pain
Recruiting NCT04865185 - Effect of Topical Lidocaine on Warm and Cold Sensation in Healthy Individuals N/A
Completed NCT05093023 - ABCB1 SNPs as Predictors of PIPN
Completed NCT05410548 - Comorbidity Screening and Referral by Prosthetists N/A
Completed NCT03021174 - Exercise and Nutrition Interventions During Chemotherapy N/A
Not yet recruiting NCT06422949 - Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral Neuropathy N/A
Terminated NCT03777956 - The Effect of Lacosamide in Peripheral Neuropathic Pain Phase 2
Terminated NCT04218448 - Evaluation of the Interest of Hypno-relaxation During Somatosensory Evoked Potentials N/A